RNA Based Therapeutics Market Size 2024-2028
The RNA based therapeutics market size is forecast to increase by USD 1.27 billion at a CAGR of 5.54% between 2023 and 2028. The market is experiencing significant growth due to several key drivers. First, the increasing number of clinical studies focusing on messenger ribonucleic acid (mRNA) technology for cancer treatment is fueling market expansion. Additionally, the immunologic characteristics of RNA-based therapeutics, such as their ability to elicit both T-cell and B-cell responses, make them an attractive option for vaccine development against infectious diseases and genetic disorders. Furthermore, pharmacologic frontiers in RNA-based therapeutics are expanding, offering new opportunities for treating rare conditions. However, the high cost of developing RNA-based therapeutics remains a significant challenge for market growth. Despite this, the potential benefits of these innovative treatments continue to draw investment and collaboration from industry players.
What will be the Size of the Market During the Forecast Period?
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by Route of Administration
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
- 2.3 Factors of disruption
- Overview on factors of disruption
- 2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028
3 Market Landscape
- 3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
- 3.2 Market characteristics
- Market characteristics analysis
4 Market Sizing
- 4.1 Market definition
- Offerings of companies included in the market definition
- 4.2 Market segment analysis
- 4.4 Market outlook: Forecast for 2023-2028
- Chart on Global - Market size and forecast 2023-2028 ($ million)
- Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Data Table on Global Market: Year-over-year growth 2023-2028 (%)
5 Historic Market Size
- 5.1 Global RNA Based Therapeutics Market 2018 - 2022
- Historic Market Size - Data Table on Global RNA Based Therapeutics Market 2018 - 2022 ($ million)
- 5.2 Type segment analysis 2018 - 2022
- Historic Market Size - Type Segment 2018 - 2022 ($ million)
- 5.3 Route of Administration segment analysis 2018 - 2022
- Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million)
- 5.4 Geography segment analysis 2018 - 2022
- Historic Market Size - Geography Segment 2018 - 2022 ($ million)
- 5.5 Country segment analysis 2018 - 2022
- Historic Market Size - Country Segment 2018 - 2022 ($ million)
6 Qualitative Analysis
- 6.1 Impact of AI on the Global RNA Based Therapeutics Market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2023 and 2028
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2023 and 2028
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2023 and 2028
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2023 and 2028
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2023 and 2028
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2023 and 2028
- 7.7 Market condition
- Chart on Market condition - Five forces 2023 and 2028
8 Market Segmentation by Type
- 8.1 Market segments
- Chart on Type - Market share 2023-2028 (%)
- Data Table on Type - Market share 2023-2028 (%)
- 8.2 Comparison by Type
- Chart on Comparison by Type
- Data Table on Comparison by Type
- 8.3 mRNA therapeutics - Market size and forecast 2023-2028
- Chart on mRNA therapeutics - Market size and forecast 2023-2028 ($ million)
- Data Table on mRNA therapeutics - Market size and forecast 2023-2028 ($ million)
- Chart on mRNA therapeutics - Year-over-year growth 2023-2028 (%)
- Data Table on mRNA therapeutics - Year-over-year growth 2023-2028 (%)
- 8.4 Antisense oligonucleotide (ASO) therapeutics - Market size and forecast 2023-2028
- Chart on Antisense oligonucleotide (ASO) therapeutics - Market size and forecast 2023-2028 ($ million)
- Data Table on Antisense oligonucleotide (ASO) therapeutics - Market size and forecast 2023-2028 ($ million)
- Chart on Antisense oligonucleotide (ASO) therapeutics - Year-over-year growth 2023-2028 (%)
- Data Table on Antisense oligonucleotide (ASO) therapeutics - Year-over-year growth 2023-2028 (%)
- 8.5 RNA interference (RNAi) therapeutics - Market size and forecast 2023-2028
- Chart on RNA interference (RNAi) therapeutics - Market size and forecast 2023-2028 ($ million)
- Data Table on RNA interference (RNAi) therapeutics - Market size and forecast 2023-2028 ($ million)
- Chart on RNA interference (RNAi) therapeutics - Year-over-year growth 2023-2028 (%)
- Data Table on RNA interference (RNAi) therapeutics - Year-over-year growth 2023-2028 (%)
- 8.6 Others - Market size and forecast 2023-2028
- Chart on Others - Market size and forecast 2023-2028 ($ million)
- Data Table on Others - Market size and forecast 2023-2028 ($ million)
- Chart on Others - Year-over-year growth 2023-2028 (%)
- Data Table on Others - Year-over-year growth 2023-2028 (%)
- 8.7 Market opportunity by Type
- Market opportunity by Type ($ million)
- Data Table on Market opportunity by Type ($ million)
9 Market Segmentation by Route of Administration
- 9.1 Market segments
- Chart on Route of Administration - Market share 2023-2028 (%)
- Data Table on Route of Administration - Market share 2023-2028 (%)
- 9.2 Comparison by Route of Administration
- Chart on Comparison by Route of Administration
- Data Table on Comparison by Route of Administration
- 9.3 Intravenous (IV) - Market size and forecast 2023-2028
- Chart on Intravenous (IV) - Market size and forecast 2023-2028 ($ million)
- Data Table on Intravenous (IV) - Market size and forecast 2023-2028 ($ million)
- Chart on Intravenous (IV) - Year-over-year growth 2023-2028 (%)
- Data Table on Intravenous (IV) - Year-over-year growth 2023-2028 (%)
- 9.4 Subcutaneous (SC) - Market size and forecast 2023-2028
- Chart on Subcutaneous (SC) - Market size and forecast 2023-2028 ($ million)
- Data Table on Subcutaneous (SC) - Market size and forecast 2023-2028 ($ million)
- Chart on Subcutaneous (SC) - Year-over-year growth 2023-2028 (%)
- Data Table on Subcutaneous (SC) - Year-over-year growth 2023-2028 (%)
- 9.5 Intramuscular (IM) - Market size and forecast 2023-2028
- Chart on Intramuscular (IM) - Market size and forecast 2023-2028 ($ million)
- Data Table on Intramuscular (IM) - Market size and forecast 2023-2028 ($ million)
- Chart on Intramuscular (IM) - Year-over-year growth 2023-2028 (%)
- Data Table on Intramuscular (IM) - Year-over-year growth 2023-2028 (%)
- 9.6 Market opportunity by Route of Administration
- Market opportunity by Route of Administration ($ million)
- Data Table on Market opportunity by Route of Administration ($ million)
10 Customer Landscape
- 10.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
11 Geographic Landscape
- 11.1 Geographic segmentation
- Chart on Market share by geography 2023-2028 (%)
- Data Table on Market share by geography 2023-2028 (%)
- 11.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
- 11.3 Europe - Market size and forecast 2023-2028
- Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Chart on Europe - Year-over-year growth 2023-2028 (%)
- Data Table on Europe - Year-over-year growth 2023-2028 (%)
- 11.4 North America - Market size and forecast 2023-2028
- Chart on North America - Market size and forecast 2023-2028 ($ million)
- Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Chart on North America - Year-over-year growth 2023-2028 (%)
- Data Table on North America - Year-over-year growth 2023-2028 (%)
- 11.5 Asia - Market size and forecast 2023-2028
- Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Chart on Asia - Year-over-year growth 2023-2028 (%)
- Data Table on Asia - Year-over-year growth 2023-2028 (%)
- 11.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- 11.7 US - Market size and forecast 2023-2028
- Chart on US - Market size and forecast 2023-2028 ($ million)
- Data Table on US - Market size and forecast 2023-2028 ($ million)
- Chart on US - Year-over-year growth 2023-2028 (%)
- Data Table on US - Year-over-year growth 2023-2028 (%)
- 11.8 China - Market size and forecast 2023-2028
- Chart on China - Market size and forecast 2023-2028 ($ million)
- Data Table on China - Market size and forecast 2023-2028 ($ million)
- Chart on China - Year-over-year growth 2023-2028 (%)
- Data Table on China - Year-over-year growth 2023-2028 (%)
- 11.9 Germany - Market size and forecast 2023-2028
- Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Chart on Germany - Year-over-year growth 2023-2028 (%)
- Data Table on Germany - Year-over-year growth 2023-2028 (%)
- 11.10 UK - Market size and forecast 2023-2028
- Chart on UK - Market size and forecast 2023-2028 ($ million)
- Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Chart on UK - Year-over-year growth 2023-2028 (%)
- Data Table on UK - Year-over-year growth 2023-2028 (%)
- 11.11 Japan - Market size and forecast 2023-2028
- Chart on Japan - Market size and forecast 2023-2028 ($ million)
- Data Table on Japan - Market size and forecast 2023-2028 ($ million)
- Chart on Japan - Year-over-year growth 2023-2028 (%)
- Data Table on Japan - Year-over-year growth 2023-2028 (%)
- 11.12 France - Market size and forecast 2023-2028
- Chart on France - Market size and forecast 2023-2028 ($ million)
- Data Table on France - Market size and forecast 2023-2028 ($ million)
- Chart on France - Year-over-year growth 2023-2028 (%)
- Data Table on France - Year-over-year growth 2023-2028 (%)
- 11.13 Italy - Market size and forecast 2023-2028
- Chart on Italy - Market size and forecast 2023-2028 ($ million)
- Data Table on Italy - Market size and forecast 2023-2028 ($ million)
- Chart on Italy - Year-over-year growth 2023-2028 (%)
- Data Table on Italy - Year-over-year growth 2023-2028 (%)
- 11.14 India - Market size and forecast 2023-2028
- Chart on India - Market size and forecast 2023-2028 ($ million)
- Data Table on India - Market size and forecast 2023-2028 ($ million)
- Chart on India - Year-over-year growth 2023-2028 (%)
- Data Table on India - Year-over-year growth 2023-2028 (%)
- 11.15 Canada - Market size and forecast 2023-2028
- Chart on Canada - Market size and forecast 2023-2028 ($ million)
- Data Table on Canada - Market size and forecast 2023-2028 ($ million)
- Chart on Canada - Year-over-year growth 2023-2028 (%)
- Data Table on Canada - Year-over-year growth 2023-2028 (%)
- 11.16 Singapore - Market size and forecast 2023-2028
- Chart on Singapore - Market size and forecast 2023-2028 ($ million)
- Data Table on Singapore - Market size and forecast 2023-2028 ($ million)
- Chart on Singapore - Year-over-year growth 2023-2028 (%)
- Data Table on Singapore - Year-over-year growth 2023-2028 (%)
- 11.17 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
12 Drivers, Challenges, and Opportunity/Restraints
- 12.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028
- 12.4 Market opportunities/restraints
13 Competitive Landscape
- 13.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 13.3 Landscape disruption
- Overview on factors of disruption
- 13.4 Industry risks
- Impact of key risks on business
14 Competitive Analysis
- 14.2 Company ranking index
- 14.3 Market positioning of companies
- Matrix on companies position and classification
- 14.4 Alnylam Pharmaceuticals Inc.
- Alnylam Pharmaceuticals Inc. - Overview
- Alnylam Pharmaceuticals Inc. - Product / Service
- Alnylam Pharmaceuticals Inc. - Key offerings
- SWOT
- 14.5 Arbutus Biopharma Corp.
- Arbutus Biopharma Corp. - Overview
- Arbutus Biopharma Corp. - Product / Service
- Arbutus Biopharma Corp. - Key offerings
- SWOT
- 14.6 Arcturus Therapeutics Holdings Inc.
- Arcturus Therapeutics Holdings Inc. - Overview
- Arcturus Therapeutics Holdings Inc. - Product / Service
- Arcturus Therapeutics Holdings Inc. - Key offerings
- SWOT
- 14.7 Arrowhead Pharmaceuticals Inc.
- Arrowhead Pharmaceuticals Inc. - Overview
- Arrowhead Pharmaceuticals Inc. - Product / Service
- Arrowhead Pharmaceuticals Inc. - Key offerings
- SWOT
- 14.8 AstraZeneca Plc
- AstraZeneca Plc - Overview
- AstraZeneca Plc - Product / Service
- AstraZeneca Plc - Key news
- AstraZeneca Plc - Key offerings
- SWOT
- 14.9 Benitec Biopharma Inc.
- Benitec Biopharma Inc. - Overview
- Benitec Biopharma Inc. - Product / Service
- Benitec Biopharma Inc. - Key offerings
- SWOT
- 14.10 Biogen Inc.
- Biogen Inc. - Overview
- Biogen Inc. - Product / Service
- Biogen Inc. - Key news
- Biogen Inc. - Key offerings
- SWOT
- 14.11 BioNTech SE
- BioNTech SE - Overview
- BioNTech SE - Product / Service
- BioNTech SE - Key offerings
- SWOT
- 14.12 CureVac AG
- CureVac AG - Overview
- CureVac AG - Product / Service
- CureVac AG - Key offerings
- SWOT
- 14.13 Gennova Biopharmaceuticals Ltd
- Gennova Biopharmaceuticals Ltd - Overview
- Gennova Biopharmaceuticals Ltd - Product / Service
- Gennova Biopharmaceuticals Ltd - Key offerings
- SWOT
- 14.14 Ionis Pharmaceuticals Inc.
- Ionis Pharmaceuticals Inc. - Overview
- Ionis Pharmaceuticals Inc. - Product / Service
- Ionis Pharmaceuticals Inc. - Key news
- Ionis Pharmaceuticals Inc. - Key offerings
- SWOT
- 14.15 Moderna Inc.
- Moderna Inc. - Overview
- Moderna Inc. - Product / Service
- Moderna Inc. - Key offerings
- SWOT
- 14.16 Novo Nordisk AS
- Novo Nordisk AS - Overview
- Novo Nordisk AS - Business segments
- Novo Nordisk AS - Key news
- Novo Nordisk AS - Key offerings
- Novo Nordisk AS - Segment focus
- SWOT
- 14.17 Sarepta Therapeutics Inc.
- Sarepta Therapeutics Inc. - Overview
- Sarepta Therapeutics Inc. - Product / Service
- Sarepta Therapeutics Inc. - Key offerings
- SWOT
- 14.18 Silence Therapeutics plc
- Silence Therapeutics plc - Overview
- Silence Therapeutics plc - Product / Service
- Silence Therapeutics plc - Key offerings
- SWOT
15 Appendix
- 15.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 15.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 15.4 Research methodology
- 15.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 15.9 360 degree market analysis
- 360 degree market analysis
- 15.10 List of abbreviations
What is Impact of AI on the RNA-Based Therapeutics Market?
With the growing adoption of AI across industries, Technavio has analyzed its impact on global RNA-based therapeutics market, centered on groundbreaking treatments like mRNA vaccines and RNA interference (RNAi) therapies, is advancing rapidly with the integration of Artificial Intelligence (AI). AI is driving innovation in drug discovery, personalized medicine, clinical trials, and patient monitoring. This analysis delves into AI's impact on the RNA-based therapeutics market, backed by data and real-world examples.
These insights, available exclusively through Technavio, provide an unparalleled significant impact of AI on the RNA-based therapeutics market, backed by real-world examples and data.
The report provides details of AI's impact on various segment
- AI in Drug Discovery and Development
- Enhanced Target Identification
- Optimized Molecular Design
- Case Study
- AI in Clinical Trials
- Patient Stratification and Recruitment
- Real-time Monitoring and Adaptive Trials
- Case Study
- AI in Manufacturing and Quality Control
- Process Optimization
- Quality Assurance Automation
- Case Study
- AI in Personalized Medicine and Patient Monitoring
- Personalized Therapy Optimization
- Continuous Health Monitoring
- Case Study
Learn more about how AI is transforming RNA-based Therapeutics Market - Buy Full Report Now
Report on How AI is Driving Market Transformation 
Get the report (PDF) sent to your email within minutes.